|
Volumn 245, Issue 1, 1995, Pages 45-49
|
A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients - A re-evaluation of the North American risperidone study
a b c d e |
Author keywords
Haloperidol; Negative symptoms; Neuroleptics; Risperidone; Schizophrenia
|
Indexed keywords
HALOPERIDOL;
NEUROLEPTIC AGENT;
RISPERIDONE;
ARTICLE;
CANADA;
DEPRESSION;
DRUG EFFECT;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
PRIORITY JOURNAL;
RATING SCALE;
REGRESSION ANALYSIS;
SCHIZOPHRENIA;
SYMPTOMATOLOGY;
UNITED STATES;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA DISEASES;
CHRONIC DISEASE;
DOUBLE-BLIND METHOD;
HALOPERIDOL;
HUMAN;
ISOXAZOLES;
PIPERIDINES;
RISPERIDONE;
SCHIZOPHRENIA;
|
EID: 0028946201
PISSN: 09401334
EISSN: 14338491
Source Type: Journal
DOI: 10.1007/BF02191543 Document Type: Article |
Times cited : (144)
|
References (19)
|